Brevan Howard Capital Management’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Sell
34,285
-10,943
-24% -$391K 0.01% 678
2025
Q4
$1.34M Buy
45,228
+2,383
+6% +$85.1K 0.01% 641
2025
Q3
$1.38M Sell
42,845
-86,035
-67% -$2.25M 0.01% 753
2025
Q2
$2.73M Buy
128,880
+69,806
+118% +$1.17M 0.02% 612
2025
Q1
$890K Buy
59,074
+21,936
+59% +$380K 0.01% 543
2024
Q4
$687K Buy
37,138
+26,998
+266% +$484K ﹤0.01% 526
2024
Q3
$190K Sell
10,140
-28,710
-74% -$607K ﹤0.01% 1002
2024
Q2
$962K Buy
38,850
+6,802
+21% +$188K 0.01% 389
2024
Q1
$985K Buy
32,048
+7,838
+32% +$212K 0.01% 276
2023
Q4
$625K Buy
+24,210
New +$640K 0.01% 389

Other funds holding DK

Brevan Howard Capital Management's DK Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Delek US (DK) stake by 24% in Q1 2026, selling an estimated $391K and leaving 34,285 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #678.

Brevan Howard Capital Management first reported a position in DK in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.73M in Q2 2025. 276 funds tracked by Wall St. Rank hold DK as of Q1 2026.

  • Brevan Howard Capital Management held 34,285 shares of Delek US worth $1.55M as of Q1 2026.
  • Brevan Howard Capital Management sold 10,943 Delek US shares in Q1 2026, an estimated $391K.
  • Delek US made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #678 holding.
  • Brevan Howard Capital Management first reported a position in Delek US in Q4 2023 and has held it in 10 quarters since.
  • Brevan Howard Capital Management's Delek US position peaked at $2.73M in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Delek US as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.